These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 4628582)
1. [Cytarabine: mechanism of action and clinical application]. Eridani S Haematologica; 1972; 57(7):341-58. PubMed ID: 4628582 [No Abstract] [Full Text] [Related]
2. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response]. Furusawa S; Adachi Y; Nomura T; Komiya M Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065 [No Abstract] [Full Text] [Related]
3. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man. Killmann SA Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680 [No Abstract] [Full Text] [Related]
4. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes. Inagaki A; Nakamura T; Wakisaka G Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487 [No Abstract] [Full Text] [Related]
5. Current and future aspects on the clinical use of Ara-C in leukemia. Proceedings from a symposium held at the 3rd European Conference on Clinical Oncology and Cancer Nursing, June 19, 1985, in Stockholm. Scand J Haematol Suppl; 1986; 44():1-74. PubMed ID: 3457436 [No Abstract] [Full Text] [Related]
6. [Biochemical basis of the treatment of leukemia with cytosine-arabinoside]. Wilmanns H Schweiz Med Wochenschr; 1970 Feb; 100(7):323-5. PubMed ID: 5413922 [No Abstract] [Full Text] [Related]
7. Cytarabine (Ara-C): a drug profile. Berg S J Assoc Pediatr Oncol Nurses; 1984; 1(2):30-2. PubMed ID: 6565043 [No Abstract] [Full Text] [Related]
10. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo. Wilmanns W Natl Cancer Inst Monogr; 1971 Dec; 34():153-9. PubMed ID: 5291099 [No Abstract] [Full Text] [Related]
11. Brook Lodge Symposium on "The pharmacology of Cytosar-U as it relates to its therapeutic usage". Kalamazoo, Michigan, December 13-15, 1981. Med Pediatr Oncol; 1982; 10 Suppl 1():1-272. PubMed ID: 7162457 [No Abstract] [Full Text] [Related]
12. Cytarabine. Med Lett Drugs Ther; 1971 Jan; 13(1):3-4. PubMed ID: 5284023 [No Abstract] [Full Text] [Related]
13. [Inhibition of DNA synthesis in peripheral leukemic cells by cytosine-arabinoside; attempt at deriving therapeutic application]. Schleusner A; Schütt M; Langen P Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):218-25. PubMed ID: 6168530 [No Abstract] [Full Text] [Related]
15. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin]. Schmalzl F; Braunsteiner H Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111 [No Abstract] [Full Text] [Related]
16. Effect of hydroxyurea and cytarabine on rodent epidermal cells. Stoughton RB Arch Dermatol; 1971 Aug; 104(2):161-5. PubMed ID: 5093169 [No Abstract] [Full Text] [Related]
17. Handling punctate keratitis resulting from systemic cytarabine. Friedland S; Loya N; Shapiro A Ann Ophthalmol; 1993 Aug; 25(8):290-1. PubMed ID: 8239322 [TBL] [Abstract][Full Text] [Related]
18. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission]. Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157 [No Abstract] [Full Text] [Related]
19. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y). Hoovis ML; Chu MY Cancer Res; 1973 Mar; 33(3):521-5. PubMed ID: 4734734 [No Abstract] [Full Text] [Related]
20. Review of recent studies of cellular proliferation in acute leukemia. Clarkson BD Natl Cancer Inst Monogr; 1969 May; 30():81-120. PubMed ID: 5260445 [No Abstract] [Full Text] [Related] [Next] [New Search]